HB 477 revises Florida's definition of "drug paraphernalia" to exclude specific testing products like fentanyl test strips and reagent kits. These products, which identify dangerous substances such as fentanyl, xylazine, cocaine, or amphetamines, are now explicitly exempt from being classified as drug paraphernalia. The bill excludes only products used solely to detect presence - not quantity or potency - and aims to support harm reduction by enabling users to avoid lethal substances. This change directly affects Floridians who use these testing tools to prevent overdoses, aligning with legislative findings on the opioid crisis.
Recovery of Damages for Medical Negligence Resulting in Death; Removes provision precluding certain persons from recovering damages for medical negligence resulting in death.
HB 407, titled the "Connecting to Care Act," authorizes pharmacists in Florida to administer specific medications under certain conditions. It expands pharmacists' roles by allowing them to deliver long-acting antipsychotics or opiate addiction treatments via injection, following physician-established protocols, after completing an 8-hour training course. Pharmacists must work within licensed facilities with privacy for injections, maintain separate prescriptions per dose, and adhere to safety protocols. This directly affects pharmacists, healthcare facilities, and patients receiving medication-assisted treatment for behavioral health conditions.
